Heng Fai Ambrose Chan

CEO Heng Fai Ambrose Chan bought 250,000 shares of HWH at $2.00; stock now $1.22, down 84.3% from 52-week high.

CEO Heng Fai Ambrose Chan purchased 250,000 shares at $2.00 on 2026-06-08, increasing his holdings to 5,261,719 shares (5.26M shares). The stock now trades at $1.22, which is -84.3% from the 52-week high of $7.77, and has declined -10.3% over the 90-day period. Across his open-market history, his prior 8 buys averaged -11.2% return over 30 days and -19.1% over 90 days, with a 25.00% win rate, suggesting his buy decisions have historically underperformed. The company is unprofitable with a net income of $-626,197.00 over its most recent full fiscal year, annual revenue growth of -30.8%, and latest quarterly revenue of only $64,200.00, establishing a difficult fundamental backdrop for this purchase.

CEO Chan Heng Fai Ambrose sold 500,000 shares at $2.67 on 2025-09-12; stock now $4.27 (+0.0% from 52-week high), up +261.9% over 30 days.

Chan Heng Fai Ambrose, CEO of Alset Inc., sold 500,000 shares at $2.67 on 2025-09-12, reducing his holdings from 31.82M to 31.32M shares (-1.6% of pre-transaction holdings). The sale occurred during a period of sharp upward price momentum: the stock has risen +261.9% over the past 30 days and +357.5% over the past 90 days, now trading at $4.27, which matches the 52-week high. At the time of sale, the stock was valued at approximately $2.67, well below its current price, suggesting the insider sold during a relative low point prior to subsequent acceleration. Across his 11 prior open-market sales on other tickers, his well-timed sell rate was 72.73% (higher is better for sells); however, at this specific ticker (AEI), only 1 of 4 prior measurable buys were well-timed at the 90-day horizon. The company remains unprofitable (full-year net income was $-8,221,441.00, latest quarter revenue was $1,098,962.00) and revenue declined -4.4% annually, creating a structural disconnect between the stock's recent momentum and underlying operating performance.

CEO Chan Heng Fai Ambrose buys 33,000 shares at $1.29; stock now $1.18, down 5.6% in 30 days.

Chan Heng Fai Ambrose, the CEO, purchased 33,000 shares at $1.29, increasing his holdings from 31,789,903 to 31,822,903 shares. The stock has declined to $1.18, representing a -5.6% change over the past 30 days. His cross-ticker track record shows 9 prior buys averaging -31.8% over 30 days with a 22.22% win rate, while his same-ticker history at AEI shows 2 of 5 prior buys were well-timed at the 90-day mark. Notably, Alset Inc. reported a net loss of $-8.2M on quarterly revenue of $1.1M and revenue declined 4.4% year-over-year, creating a backdrop of operational weakness rather than growth signals.

Director Chan Heng Fai Ambrose sold 1,689,693 shares (100% of holdings) for $1,122,919.96 across 7 transactions on Apr 2-4 at blended avg price of $0.66.

Chan Heng Fai Ambrose executed a complete exit from IBO over three trading days, selling 7 separate tranches totaling 1,689,693 shares for $1,122,919.96 and reducing his holdings to zero. The sales occurred at prices ranging from $0.58 to $0.96, with a blended average of $0.66, while the stock currently trades at $0.96—80.6% below its 52-week high of $4.96. The timing is notable: these sales follow a prior pattern at this ticker where three additional sells occurred on March 31 and April 1, suggesting an accelerating liquidation across four days. Against his cross-ticker track record of 16 prior buys averaging +25.2% gain over 30 days and +162.3% over 90 days, this complete exit from his sole measurable position at IBO is a material shift, particularly given the company's quarter with only $50,000.00 in revenue yet $4,241,000.00 in net income, highlighting potential earnings quality concerns that warrant scrutiny of the underlying business.

Director Chan Heng Fai Ambrose sold 2,526,918 shares (77.5% of holdings) across 4 transactions for $2,912,821.44; stock down 60.4% in 30 days, 63.0% in 90 days.

Director Chan Heng Fai Ambrose executed 4 separate sales totaling 2,526,918 shares for $2,912,821.44 between March 31 and April 1, with prices ranging from $0.98 to $1.45 and a blended average of $1.15. The current price of $0.57 represents an 88.5% decline from the 52-week high of $4.96 and marks a 60.4% drop over 30 days and 63.0% over 90 days—a dramatic deterioration in fundamental value after these sales. The company reported recent quarterly revenue of $50,000.00 against a market cap of $6,888,684.84, yet posted a $4,241,000.00 net income in the latest quarter despite being unprofitable over its most recent full fiscal year, a fundamental inconsistency that demands scrutiny. This appears to be a substantial liquidation of the director's position (from 3,260,976 to 734,058 shares, a net reduction of 77.5%), occurring as the stock has experienced severe downward price pressure post-transaction.

Director Chan Heng Fai Ambrose bought 3,527 shares (4 transactions) at $3.04 avg; stock now $1.25 (-69.2% from 52-week high).

Director Chan Heng Fai Ambrose executed 4 separate purchases totaling 3,527 shares for $10,718.82 between January 27 and February 5, 2025, raising his holdings from 9,727 to 13,254 shares (+36.3%). The purchases occurred at prices ranging from $2.94 to $3.23, with a blended average of $3.04. The company operates under challenging fundamentals: revenue of $2,084,658.00 in the latest quarter declined -32.4% year-over-year, with net losses of $-466,145.00 in that period and unprofitable full-year results. The stock has since fallen to $1.25, representing a -69.2% decline from its 52-week high of $4.06. At SHRG specifically, Chan's prior 3 trades (all buys on 2025-01-21, 2025-01-22, and 2025-01-23) show mixed near-term outcomes: one generated +28.1% over 30 days while another showed -17.0% over the same window, with 90-day outcomes not yet measurable. The timing pattern across his cross-ticker buy history shows no well-timed purchases at the 90-day mark.

CEO buys 50,000 AEI shares at $1.23 on 2025-02-13; stock now $1.16; 5 purchases in 3 weeks as fundamentals improve sharply.

Chan Heng Fai Ambrose purchased 50,000 shares at $1.23 on 2025-02-13, adding to a pattern of five buys within three weeks (2025-01-22 through 2025-02-13), totaling significant accumulated shares at AEI. The stock has declined 5.7% since the transaction (from $1.23 to $1.16), though it remains up 41.4% over the past 30 days and is still -41.1% from its 52-week high of $1.97. The rapid accumulation pattern is contextualized by strong recent fundamentals: revenue surged 393.0% year-over-year to $5.0M in the latest quarter, with net income of $1.7M, though the company was unprofitable over the most recent full fiscal year. The extended buying across a compressed timeframe alongside improving quarterly trends warrants monitoring, especially given the gap between the transaction price and the earlier 52-week high.

CEO Chan Heng Fai Ambrose buys 20,244 shares of Alset Inc. at $1.07; executes 5th consecutive AEI purchase in 3 weeks

Chan Heng Fai Ambrose purchased 20,244 shares of Alset Inc. (AEI) at $1.07 on 2025-02-12, increasing his holdings from 6,329,498 to 6,349,742 shares. This transaction is part of a striking pattern: the CEO has executed 5 open-market buys in 15 days (spanning 2025-01-22 through 2025-02-13), with no selling activity during the same window. The stock has appreciated 31.8% over the past 30 days and trades at $1.16, well above the recent 52-week low of $0.46, though still -41.1% below the 52-week high of $1.97. Fundamentals show revenue of $4,960,711.00 and net income of $1,716,363.00 in the latest quarter, with annual revenue growth of +393.0%, though the company was unprofitable over its most recent full fiscal year. The concentrated buying pattern across multiple tranches warrants attention as a potential signal of perceived value or stabilization, particularly given the company's recent profitability swing and growth trajectory, but outcomes for the same-ticker buys are not yet measurable.

CEO Chan Heng Fai Ambrose buys 291,060 shares at $1.01 avg for $294,149.40; stock down 30.2% in 90 days

CEO Chan Heng Fai Ambrose executed 2 separate purchases totaling 291,060 shares for $294,149.40, increasing holdings by 4.8% to 6.33M shares. The transactions occurred at a blended average price of $1.01, but the current price of $0.95 reflects a decline of 51.8% from the 52-week high and a 90-day decline of -30.2%. Within his same-ticker history at AEI, 2 of 3 prior measurable buys (August 2024) achieved positive 90-day returns of +27.8% and +26.0%, though his cross-ticker track record shows a 90-day win rate of 71.43%, suggesting selective execution success. The company is fundamentally challenged: unprofitable on a full-year basis despite recent quarterly profitability ($1.7M net income on $5.0M revenue) and rapid annual revenue growth of +393.0%, creating an asymmetry between headline growth and bottom-line sustainability.

CEO Chan Heng Fai Ambrose buys 100,000 AEI shares at $0.93; stock down 56.4% from high despite 393% annual revenue growth

CEO Chan acquired 100,000 shares at $0.93 on 2025-01-27, the fifth open-market purchase at AEI within the past six months. The company has posted exceptional top-line growth (+393.0% annual revenue growth) and returned to profitability with $1,716,363.00 net income in the latest quarter, yet the stock has declined 56.4% from its 52-week high and trades at $0.86, down 31.7% in the last 30 days. Chan's prior four buys at this ticker showed a 75% win rate on 90-day returns (3 of 4 measurable outcomes were positive), establishing a pattern of well-timed entry points at AEI specifically. The repeated buying into a declining price despite strong operational fundamentals presents a tension between operational performance and market sentiment that deserves investor attention.